In addition, we show that the crosstalk between the aforementioned receptors triggers the expression and function of the cytokine interleukin‐11 (IL11), which leads to migratory and invasive capabilities of CAFs derived from BC patients. This evidence concerns the gene IL11 and breast cancer.